Quanterix Corporation Estimates – NASDAQ:QTRX

1,558 stock awards convert into shares for Quanterix (QTRX) technology chief Michael Francis Miller.

TD Cowen Maintains Hold on Quanterix, Raises Price Target to $3.5

/C O R R E C T I O N -- ALZpath, Inc./

ALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer's Disease Biomarker Research

Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration Approvals

Quanterix, Innovita Biological Technology Receives Regulatory Nods From China For Quanterix SIMOA Technology, Neurology Biomarker Testing

$QTRX stock is down 9% today. Here's what we see in our data.

Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Names Dr. Yuri Fesko Chief Medical Officer

Quanterix (QTRX) Q2 2026 Earnings Call Transcript

Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test

Quanterix (QTRX) Earnings Shake Up The Story As Fair Value Still Sits Higher

Quanterix Cuts 2026 Revenue Outlook as Commercial Challenges Delay Cash-Flow Break-Even